PLCG2 C2 domain mutations co-occur with BTK and PLCG2 resistance mutations in chronic lymphocytic leukemia undergoing ibrutinib treatment
D Jones; J A Woyach; W Zhao; S Caruthers; H Tu; J Coleman; J C Byrd; A J Johnson; G Lozanski
Author Information: Department of Pathology, The Ohio State University and James Cancer Hospital, Columbus, OH, USA;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.